Biogen (BIIB) PT Raised to $360 at Oppenheimer

June 12, 2023 7:52 AM EDT
Get Alerts BIIB Hot Sheet
Price: $208.87 +2.44%

Rating Summary:
    27 Buy, 16 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 3 | Down: 6 | New: 3
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Biogen (NASDAQ: BIIB) to $360.00 (from $350.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change